Drug Development Clinical Trials Product Development Generic Drugs Therapeutics Research and Development Oncology Immunology Insmed Generic Medicines Bristol-Myers Squibb Company Clinical-stage Biopharmaceutical Companies Oncology Treatments Duchenne Muscular Dystrophy Corporate Acquisitions Teva Pharmaceutical Industries Limited Respiratory Diseases Radiopharmaceuticals Animal Health Takeda Biopharmaceuticals Rare Diseases Vaccines Wound Care Product Launches Pulmonary Arterial Hypertension FDA Approvals Ophthalmology Dermatology Cardiovascular Treatments Central Nervous System Disorders Vaccine Development Regulatory Affairs Market Performance Epinephrine Delivery
Want to see what podcasts are saying about this topic? Search across 145K+ podcasts. Explore Radar
A newly announced long-term BARDA procurement pact and scheduled manufacturing changes position the company to rely on government purchases for a second-half revenue ramp.
